Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment

Journal of Clinical Microbiology

Volumn 52, Issue 6, 2014, Pages 2193-2195

  Juniastuti, J ^a,b   Wibowo, Bogi P ^c   Wibawa, I D N ^d   Utsumi, Takako ^b,f   Mustika, Syifa ^c   Amin, Mochamad ^a,b   Wahyuni, Rury M ^a,b   Kurniawan, Hendra ^a   Hendrayana, Agus ^e   Setiawan, Poernomo B ^a   Yamani, Laura N ^f   Soetjipto, S ^a,b   Yano, Yoshihiko ^f   Hotta, Hak ^f   Hayashi, Yoshitake ^f   Lusida, Maria I ^a,b  

^a AIRLANGGA UNIVERSITY   (Indonesia)

^b Indonesia Japan Collaborative Research Center for Emerging and Reemerging Infectious Diseases   (Indonesia)

^c Saiful Anwar General Hospital   (Indonesia)

^d Sanglah General Hospital   (Indonesia)

^e UDAYANA UNIVERSITY   (Indonesia)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 28B; PEGINTERFERON; RIBAVIRIN; ALPHA INTERFERON; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HETEROZYGOTE; HUMAN; INDONESIA; JAVANESE (PEOPLE); MALE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENE FREQUENCY; GENETICS; GENOTYPE; HEPATITIS C, CHRONIC; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INDONESIA; INTERFERON-ALPHA; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBAVIRIN; TREATMENT OUTCOME;

EID: 84901660367     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00768-14     Document Type: Article

References (15)

1. Akkarathamrongsin S, Praianantathavorn I, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y. 2010. Geographic distribution of hepatitisCvirus genotype 6 subtypes in Thailand. J. Med. Virol. 82:257-262. http://dx.doi.org/10.1002/jmv.21680
2. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973. http://dx.doi.org/10.1002/hep.20819 (Pubitemid 41401136)
3. Santos C, Reisa A, dos Santos CV, Damasa C, Silva MH, Vianaa MV, Ferrazd ML, Carnaubab D, El-Fare F, Serrae F, Diaza RS. 2012. The use of real-time PCR to detect hepatitisCvirusRNAin dried blood spots from Brazilian patients infected chronically. J. Virol. Methods 179:17-20. http://dx.doi.org/10.1016/j. jviromet.2011.06.012
4. Akkarathamrongsin S, Sugiyama M, Matsuura K, Kurbanov F, Poovorwan Y, Tanaka Y, Mizokami M. 2010. High sensitivity assay using serum samples for IL-28B genotyping to predict treatment response in chronic hepatitis C patients. Hepatol. Res. 40:956-962. http://dx.doi.org/10.1111/j.1872-034X.2010.00702.x.
5. Kani S, Tanaka Y, Matsuura K, Watanabe T, Yatsuhashi H, Orito E, Inose K, Motojuku N, Wakimoto Y, Mizokami M. 2012. Development of new IL-28B genotyping method using Invader plus assay. Microbiol. Immunol. 56:318-323. http://dx.doi.org/10.1111/j.1348-0421.2012.00439.x.
6. Utama A, Budiarto BR, Monasari D, Octavia TI, Chandra IS, Gani RA, Hasan I, Sanityoso A, Miskad UA, Yusuf I, Lesmana LA, Sulaiman A, Tai S. 2008. Hepatitis C virus genotype in blood donors and associated liver disease in Indonesia. Intervirology 51:410-416. http://dx.doi.org/10.1159/000205515
7. Zeuzem S, Berg T, Moeller B, Hinrichsen H, Mauss S, Wedemeyer H, Sarrazin C, Hueppe D, Zehnter E, Manns P. 2009. Expert opinion on the treatment of patients with chronic hepatitis C. J. Viral Hepat. 16:75-90. http://dx.doi.org/10.1111/j.1365-2893.2008.01012.x.
8. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitisCvirus infection. N. Engl. J. Med. 347:975-982. http://dx.doi.org/10.1056/NEJMoa020047
9. Huang CF, Huang JF, Yang JF, Hsieh MY, Lin ZY, Chen SC, Wang LY, Juo SH, Chen KC, Chuang WL, Kuo HT, Dai CY, Yu ML. 2012. Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin. J. Hepatol. 56:34-40. http://dx.doi.org/10. 1016/j.jhep.2011.03.029
10. Ito K, Higami K, Masaki N, Sugiyama M, Mukaide M, Saito H, Aoki Y, Sato Y, Imamura M, Murata K, Nomura H, Hige S, Adachi H, Hino K, Yatsuhashi H, Orito E, Kani S, Tanaka Y, Mizokami M. 2011 The rs8099917 polymorphism, determined by a suitable genotyping Method, is a better predictor for response to pegylated interferon-/ribavirin therapy in Japanese patients than other SNPs associated with IL-28B. J. Clin. Microbiol. 48:1853-1860. http://dx.doi.org/10.1128/JCM. 02139-10
11. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Günthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY, Swiss Hepatitis C Cohort Study. 2010. Swiss HIV Cohort Study: genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338-1345, 1345.e1-1345.e7. http://dx.doi.org/10.1053/j.gastro.2009.12.056
12. Gonzalez SA, Keeffe EB. 2011. IL-28B as a predictor of sustained virologic response in patients with chronic hepatitis C virus infection. Gastroenterol. Hepatol. 7:366-373
13. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, OHuigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchinson JG, Goldstein DB, Carrington M. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801. http://dx.doi.org/10.1038/nature08463
14. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Müller T, Bahlo M, Stewart GJ, Booth DR, George J. 2009. IL-28B is associated with response to chronic hepatitis C interferon- and ribavirin therapy. Nat. Genet. 41:1100-1105. http://dx.doi.org/10.1038/ng.447
15. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. 2009. Genomewide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 41:1105-1109. http://dx.doi.org/10.1038/ng.449.